MC38-hCD24/hPD-L1

PDFを取得

Strain Information

表現型データ

image.pngFig.1 CD24 and PD-L1 expression in MC38-hCD24/hPD-L1 cell line

image.png

Fig.2 Tumor growth curve of MC38-hCD24/hPD-L1 syngeneic model

image.png

Fig.3 Body weight change of MC38-hCD24/hPD-L1 syngeneic model

image.png


Fig.4 The expression of hCD24 and hPD-L1 in humanized modified tumors by FACS




関連の系統

あなたも好きかも

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

詳細
Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

詳細